CSF2 and ovarian carcinoma: Purified peptide epitopes in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) induce efficient T-cell responses against peptide antigens in multiple cancers, including melanoma, breast cancer, and ovarian carcinomas [87, 88].